EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic disease risks of under-represented founder populations in New York City

Mariko Isshiki iD, Anthony J Griffen, Paul Meissner, Paulette Spencer, Michael D Cabana, Susan D Klugman, Mirtha Colón, Zoya Maksumova, Shakira Suglia iD, Carmen R Isasi, John M Greally, Srilakshmi M Raj

PLOS Genetics · 2025

DOI: 10.1371/journal.pgen.1011755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2025. Verfasst von Mariko Isshiki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America. Hauptthemen laut MEDLINE: Founder Effect, Genetic Diseases, Inborn, Genetic Predisposition to Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The detection of founder pathogenic variants, those observed in high frequency only in a group of individuals with increased inter-relatedness, can help improve delivery of health care for that community. We identified 16 groups with shared ancestry, based on genomic segments that are shared through identity by descent (IBD), in New York City using the genomic data of 25,366 residents from the All Of Us Research Program and the Mount Sinai Bio Me biobank. From these groups we defined 7 as founder populations, mostly communities currently under-represented in medical genomics research, such as Puerto Rican and Garifuna. The enrichment analysis of ClinVar pathogenic or likely pathogenic (P/LP) variants in each group identified 201 of these damaging variants across the seven founder populations. We confirmed disease-causing variants previously reported to occur at increased frequencies in Ashkenazi Jewish and Puerto Rican genetic ancestry groups, but most of the damaging variants identified have not been previously associated with any such founder populations, and most of these founder populations have not been described to have increased prevalence of the associated rare disease. Twenty-two of 47 variants meeting Tier 2 prenatal screening criteria (1/100 carrier frequency within these founder groups) have never previously been reported. We show how population structure studies can provide insights into rare diseases disproportionately affecting under-represented founder populations, delivering a health care benefit but also a potential source of stigmatization of these communities, who should be part of the decision-making about implementation into health care delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Founder EffectGenetic Diseases, InbornGenetic Predisposition to DiseaseFemaleHumansMaleGenetics, PopulationHispanic or LatinoJewsNew York CityPuerto RicoIndians, Central AmericanAfrican People

Autor:innen und Institutionen

  • Departments of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America.
  • Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
  • Cell Biology, Albert Einstein College of Medicine, Bronx, New York, United States of America.
  • Family and Social Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America.
  • Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York, United States of America.
  • Bronx Community Health Network, Bronx, New York, United States of America.

ORCID-Profile: Mariko Isshiki, Shakira Suglia

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • NHGRI NIH HHS
  • NCI NIH HHS
  • NICHD NIH HHS
  • NIH Office of the Director
  • National Cancer Institute

Zitieren

APA

Isshiki, M., Griffen, A. J., Meissner, P., Spencer, P., Cabana, M. D., Klugman, S. D., Colón, M., Maksumova, Z., Suglia, S., Isasi, C. R., Greally, J. M., & Raj, S. M. (2025). Genetic disease risks of under-represented founder populations in New York City. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011755

Vancouver

Isshiki M, Griffen AJ, Meissner P, Spencer P, Cabana MD, Klugman SD, et al. Genetic disease risks of under-represented founder populations in New York City. PLOS Genetics. 2025. doi:10.1371/journal.pgen.1011755

BibTeX
@article{Isshiki2025,
  author = {Isshiki, Mariko and Griffen, Anthony J and Meissner, Paul and Spencer, Paulette and Cabana, Michael D and Klugman, Susan D and Colón, Mirtha and Maksumova, Zoya and Suglia, Shakira and Isasi, Carmen R and Greally, John M and Raj, Srilakshmi M},
  title = {Genetic disease risks of under-represented founder populations in New York City},
  journal = {PLOS Genetics},
  year = {2025},
  doi = {10.1371/journal.pgen.1011755}
}
Kostenlos starten →